LG 101506: RXR Modulator for Nuclear Receptor Signaling Research

Executive Summary: LG 101506 is a high-purity synthetic RXR modulator with a defined molecular formula (C25H34F2O3) and a molecular weight of 420.53 g/mol, supplied by APExBIO (product page). The compound selectively modulates Retinoid X Receptor signaling, a pathway integral to gene expression in cell differentiation, proliferation, and apoptosis (see DOI). It is highly valued in RXR signaling pathway research, especially for immune-cold tumors and metabolic disease models. LG 101506’s solubility and stability profile support robust and reproducible assay integration. The compound is intended for research use only and is not for diagnostic or therapeutic applications.

Biological Rationale

Retinoid X Receptors (RXRs) are nuclear receptors that control the expression of genes involved in development, metabolism, and immune regulation. RXR forms heterodimers with other nuclear receptors, thereby influencing cellular responses to endogenous and exogenous ligands (reference study). Modulation of RXR activity has direct implications for the regulation of gene networks implicated in cancer progression, particularly in triple-negative breast cancer (TNBC), where immune evasion mechanisms such as PD-L1 expression are tightly regulated by nuclear receptor pathways. LG 101506 enables controlled perturbation of RXR signaling for dissecting these regulatory axes.

Mechanism of Action of LG 101506 (RXR modulator)

LG 101506 acts as a small molecule modulator of RXR. Upon binding, it alters RXR’s conformational state, affecting its ability to form heterodimers with other nuclear receptors such as PPARs and LXRs. This modulation influences downstream gene expression related to differentiation, apoptosis, and metabolic regulation. In cancer models, RXR activity intersects with immune checkpoint regulators, including PD-L1, whose expression can be modulated via RXR-dependent transcriptional networks (supporting evidence).

Evidence & Benchmarks

• LG 101506 is supplied with ≥98% purity and is characterized as an off-white solid; its stability is maximized at -20°C (product details).
• Solubility parameters: <42.05 mg/ml in DMSO and <21.03 mg/ml in ethanol, supporting its use in diverse cell-based and biochemical assays (specifications).
• RXR modulation by small molecules like LG 101506 influences PD-L1 stability and immune checkpoint control in TNBC models (DOI:10.1038/s41418-022-01012-0).
• The compound is valuable for dissecting RXR-dependent signaling relevant to metabolism and immune evasion (internal commentary).
• LG 101506 is intended strictly for research use and not for clinical or diagnostic purposes (APExBIO).

This article extends guidance from LG 101506 (SKU B7414): Enhancing RXR Pathway Research in Cellular Models by providing in-depth mechanistic context and evidence benchmarks directly linked to recent peer-reviewed research.

Applications, Limits & Misconceptions

LG 101506 is deployed in studies addressing RXR signaling in cancer immunology, metabolic regulation, and nuclear receptor biology. Its well-characterized solubility and stability facilitate integration into workflows targeting RXR-dependent pathways in both cell-based and in vivo models (see comparison). However, as a research-use-only compound, LG 101506 is not validated for diagnostic or therapeutic use in humans. Its effects are specific to RXR and may not extrapolate to other nuclear receptors without targeted study.

Common Pitfalls or Misconceptions

• LG 101506 is not approved for clinical or diagnostic applications; it is strictly for laboratory research.
• Long-term storage of prepared LG 101506 solutions is not recommended due to potential degradation (see APExBIO protocol).
• Effects observed in RXR-related pathways may not represent activity in unrelated nuclear receptor systems.
• Data derived from one disease model (e.g., TNBC) should not be generalized to others without validation.
• Incorrect solvent selection can impair compound solubility and assay reproducibility.

Workflow Integration & Parameters

Optimized workflow integration of LG 101506 supports reproducible results in RXR signaling pathway research. The following parameters are derived from manufacturer guidelines and peer-reviewed protocols:

Protocol Parameters

• Stock solution preparation: Dissolve LG 101506 in DMSO to a maximum of 42.05 mg/ml. For ethanol, do not exceed 21.03 mg/ml (product specs).
• Storage conditions: Store solid compound at -20°C; use freshly prepared solutions to ensure integrity.
• Working concentrations: Typical in vitro assays use final concentrations in the low micromolar range; optimal dosing should be established empirically per cell line and endpoint (protocol reference).
• Assay compatibility: Compatible with cell viability, proliferation, and cytotoxicity assays in models requiring RXR pathway modulation.
• Workflow best practice: Avoid repeated freeze-thaw cycles of stock solutions.

For more scenario-driven guidance and troubleshooting, LG 101506 (RXR modulator): Reliable Solutions for Nuclear Receptor Assays provides practical laboratory recommendations. This article expands on that guidance by integrating recent mechanistic evidence.

Conclusion & Outlook

LG 101506, offered by APExBIO, is a rigorously characterized RXR modulator supporting advanced research into nuclear receptor signaling and metabolism regulation. Its defined physicochemical properties and high purity enable robust studies into RXR-dependent pathways, including those that underpin immune evasion in cancer. Recent peer-reviewed findings emphasize the importance of RXR and related networks in modulating immune checkpoints like PD-L1, validating LG 101506’s value for translational research (see DOI). As research progresses, LG 101506 will remain a benchmark tool for dissecting the chemical biology of RXR in both health and disease models.